AI-generated summary
The authors systematically reviewed six clinical trials testing photobiomodulation applied before chemotherapy to prevent oral mucositis. They report that most studies showed benefit, with one exception finding no benefit from laser use, but the wide variation in irradiation protocols made an optimal protocol hard to determine. The authors call for further well-designed, controlled, blinded studies.
- Studies included
- 6
- Who or what was studied
- Patients receiving chemotherapy, as studied in six clinical trials; the number of patients is not stated in the abstract.
- Wavelengths
- 630, 830 nm
- Limits stated in the abstract
- The abstract notes wide variability in irradiation parameters across studies and calls for further well-designed, controlled, blinded trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 to 830 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Systematic review, Risk of bias, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.